Cutaneous graft-versus-host disease on 7th day of blood transfusion in an adult male
Keywords:
Graft-versus-host diseaseAbstract
Graft-versus-host disease (GVHD) occurs when immunologically competent cells are introduced into an immunoincompetent host. The leading cause of GVHD is hematopoietic cell transplantation (HCT). Solid organ transplants, blood transfusions, and maternal-fetal transfusions also reportedly cause GVHD. We report a case of a 58-year-old male who presented with large erythematous to violaceous papules and plaques scattered on trunk and limbs, on the 7th day of whole blood transfusion. There was no evidence of systemic involvement. Diagnosis was confirmed on histopathological findings of skin lesion. Patient was treated with local steroids with resolution of lesions.References
Aractingi S, Chocidow O. Cutaneous graft-versus host disease. Arch Dermatol 1998; 134: 602-12.
Horn TD. Acute cutaneous eruption after marrow ablation; roses by other names? J Cutan Pathol 1994; 21: 385-92.
Horn TD, Redd JV, Karp JE et al. Cutaneous eruption of lymphocyte recovery. Arch Dermatol 1989; 125: 1512-7.
Zeiser R, Marks R, Bertz H. Immunopathogenesis of acute graft-versus-host disease: implications for novel preventive and therapeutic strategies. Ann Hematol 2004; 83: 551-65.
Flowers ME, Kansu E, Sullivan KM. Pathophysiology and treatment of graft-versus-host disease. Hematol Oncol Clin North Am 1999; 13: 1091-1112.
Darmstadt GL, Donnenberg AD, Vogelsang GB et al. Clinical, laboratory, and histopathologic indicators of the development of progressive acute graft-versus-host disease. J Invest Dermatol 1992; 99: 397-402.
Schmuth M, Vogel W, Weinlich G et al. Cutaneous lesions as the presenting sign of acute graft-versus-host disease following liver transplantation. Br J Dermatol 1999; 141: 901-4.
Przepiorka D, Devine S, Fay J et al. Practical considerations in the use of tacrolimus for allogeneic marrow transplantation. Bone Marrow Transplant 1999; 24: 1053-6.
Patriarca F, Sperotto A, Damiani D. Infliximab treatment for steroid-refractory acute graft-versus-host disease. Haematologica 2004; 89: 1352-9.
